CFB
REPL icon

Cullen/Frost Bankers’s Replimune Group REPL Stock Holding History

Cullen/Frost Bankers’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Buy
+1,422
New +$10.9K ﹤0.01% 1095

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cullen/Frost Bankers's REPL Position: Q1 2026 in Review

Cullen/Frost Bankers opened a new position in Replimune Group (REPL) in Q1 2026: 1,422 shares worth $10.9K. The stake represents ﹤0.01% of the portfolio and ranks #1095 among its holdings.

180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Cullen/Frost Bankers held 1,422 shares of Replimune Group worth $10.9K as of Q1 2026.
  • Replimune Group was a new Cullen/Frost Bankers position in Q1 2026.
  • Replimune Group made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q1 2026, its #1095 holding.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.